CMGGF(CMGGF)
CMGGF
No analyst ratings available
No analyst price targets available for CMGGF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $130.60B | $148.39B | $167.27B | $214.74B | $203.21B |
| Low | $128.54B | $138.29B | $159.99B | $205.40B | $194.37B |
| High | $133.62B | $162.33B | $177.43B | $227.78B | $215.55B |
| EBITDA Avg | $101.80B | $114.81B | $129.29B | $151.87B | $186.84B |
| Low | $96.19B | $108.50B | $122.19B | $143.54B | $176.56B |
| High | $109.62B | $123.62B | $139.21B | $163.51B | $201.19B |
| EBIT Avg | $99.11B | $111.61B | $125.55B | $147.36B | $181.79B |
| Low | $93.51B | $105.30B | $118.45B | $139.02B | $171.51B |
| High | $106.94B | $120.42B | $135.46B | $158.99B | $196.14B |
| Net Income Avg | $70.21B | $79.06B | $88.94B | $104.38B | $128.78B |
| Low | $66.24B | $74.59B | $83.91B | $98.48B | $121.49B |
| High | $75.75B | $85.30B | $95.96B | $112.62B | $138.94B |
| EPS Avg | $20.56 | $23.15 | $26.04 | $30.57 | $37.71 |
| Low | $19.40 | $21.84 | $24.57 | $28.84 | $35.58 |
| High | $22.18 | $24.98 | $28.10 | $32.98 | $40.69 |
| Analysts (Rev / EPS) | 7 / 1 | 8 / 1 | 5 / 1 | 6 / 1 | 6 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $1.74T | $1.76T |
| Low | $1.74T | $1.76T |
| High | $1.74T | $1.76T |
| EBITDA Avg | — | — |
| Low | — | — |
| High | — | — |
| EBIT Avg | — | — |
| Low | — | — |
| High | — | — |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — |